Journal of Clinical Endocrinology & Metabolism, Vol 76, 763-768, Copyright © 1993 by Endocrine Society

ARTICLES

Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis

ZM Lei, CV Rao, SR Lincoln and DM Ackermann
Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Kentucky 40292.

Adenomyosis is a benign disease in women in which myometrium is invaded by endometrial glands and stroma. Our laboratory recently demonstrated that normal human endometrial glands and stroma express the hCG/LH receptor gene. This prompted us to investigate whether invading glands and stroma in adenomyosis also express this receptor gene. Fifteen hysterectomy specimens with confirmed histological diagnosis of adenomyosis were examined for hCG/LH receptors by in situ hybridization and immunocytochemistry. The results showed that invading glands contained more receptor mRNA and receptor protein than noninvading glands in the same endometrium. However, the degree of difference between invading and noninvading glands varied among the patients. The higher receptor expression in invading glands is specific because the invading and noninvading stroma showed similar receptor expression, invading and noninvading glands showed similar expression of cadherin, a cell adhesion receptor, and ectopic and eutopic endometrial glands from endometriosis showed similar hCG/LH receptor expression. In summary, the present results demonstrate that invading endometrial glands in adenomyosis selectively express more hCG/LH receptor mRNA and immunoreactive receptor protein than noninvading glands. Whether this increased receptor expression is the cause or a consequence of myometrial invasion of glands in unknown.

This article has been cited by other articles:

				G. Hudelist, A. Huber, M. Knoefler, S. Haider, A. Kolbus, K. Czerwenka, S. Helmy, E. Kubista, and C. F. Singer {beta}-HCG/LH Receptor ({beta}-HCG/LH-R) Expression in Eutopic Endometrium and Endometriotic Implants: Evidence for {beta}-HCG Sensitivity of Endometriosis Reproductive Sciences, July 1, 2008; 15(6): 543 - 551. [Abstract] [PDF]

				C. V. Rao Physiological and Pathological Relevance of Human Uterine LH/hCG Receptors Reproductive Sciences, February 1, 2006; 13(2): 77 - 78. [PDF]

				U. A. Kayisli, B. Selam, O. Guzeloglu-Kayisli, R. Demir, and A. Arici Human Chorionic Gonadotropin Contributes to Maternal Immunotolerance and Endometrial Apoptosis by Regulating Fas-Fas Ligand System J. Immunol., September 1, 2003; 171(5): 2305 - 2313. [Abstract] [Full Text] [PDF]

				E. A. Stewart Gonadotropins and the Uterus: Is There a Gonad-Independent Pathway? Reproductive Sciences, December 1, 2001; 8(6): 319 - 326. [Abstract] [PDF]

				A. Horiuchi, T. Nikaido, T. Yoshizawa, K. Itoh, Y. Kobayashi, T. Toki, I. Konishi, and S. Fujii HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro Mol. Hum. Reprod., June 1, 2000; 6(6): 523 - 528. [Abstract] [Full Text] [PDF]

				S. You, H. Kim, C.-C. Hsu, M. E. El Halawani, and D. N. Foster Three Different Turkey Luteinizing Hormone Receptor (tLH-R) Isoforms I: Characterization of Alternatively Spliced tLH-R Isoforms and Their Regulated Expression in Diverse Tissues Biol Reprod, January 1, 2000; 62(1): 108 - 116. [Abstract] [Full Text]

				X.-L. Zhou, Z. M. Lei, and Ch. V. Rao Treatment of Human Endometrial Gland Epithelial Cells with Chorionic Gonadotropin/Luteinizing Hormone Increases the Expression of the Cyclooxygenase-2 Gene J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3364 - 3377. [Abstract] [Full Text]

				L. Bernardini, I. Moretti-Rojas, M. Brush, F. J. Rojas, and J. P. Balmaceda Status of hCG/LH Receptor and G Proteins in Human Endometrium During Artificial Cycles of Hormone Replacement Therapy Reproductive Sciences, July 1, 1995; 2(4): 630 - 635. [Abstract] [PDF]